Hypophosphatemia Clinical Trials

9 recruitingLast updated: July 25, 2026

There are 9 actively recruiting hypophosphatemia clinical trials across 22 countries. Studies span Not Applicable, Phase 2, Early Phase 1, Phase 1, Phase 4. Top locations include New Haven, Connecticut, United States, Madrid, Spain, Bron, France. Updated daily from ClinicalTrials.gov.


Hypophosphatemia Trials at a Glance

9 actively recruiting trials for hypophosphatemia are listed on ClinicalTrialsFinder across 6 cities in 22 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in New Haven, Madrid, and Bron. Lead sponsors running hypophosphatemia studies include Kyowa Kirin Co., Ltd., Kyowa Kirin Pharmaceutical Development Ltd, and Hospices Civils de Lyon.

Browse hypophosphatemia trials by phase

About Hypophosphatemia Clinical Trials

Looking for clinical trials for Hypophosphatemia? There are currently 8 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Hypophosphatemia trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Hypophosphatemia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Not Applicable

Phosphorus-31 Spectroscopy in Phosphate Diabetes

X-linked HypophosphatemiaPhosphate Diabetes
Hospices Civils de Lyon65 enrolled2 locationsNCT06921720
Recruiting

Registry for Patients With X-Linked Hypophosphatemia

X-linked Hypophosphatemia
Kyowa Kirin Pharmaceutical Development Ltd1,489 enrolled118 locationsNCT03193476
Recruiting
Phase 2

Evaluation of Dipyridamole in Preventing Post-Transplant Hypophosphatemia in Kidney Transplant Recipients

HypophosphatemiaKidney Transplantation
Stanford University90 enrolled1 locationNCT06824454
Recruiting
Early Phase 1

The Impact of Phosphate Metabolism on Healthy Aging

RicketsHypophosphatemiaHypercalciuria+2 more
Yale University30 enrolled1 locationNCT03771105
Recruiting

Effective Dosing of Burosumab in XLH

X-linked Hypophosphatemia (XLH)
University of Nottingham120 enrolled1 locationNCT07183579
Recruiting
Not Applicable

Enteral Supplementation With Sodium Dihydrogen Phosphate and Disodium Hydrogen Phosphate Granules for the Treatment of Hypophosphatemia.

Hypophosphatemia
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology60 enrolled1 locationNCT07233889
Recruiting
Phase 1Phase 2

A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia

X-linked Hypophosphatemia
Kyowa Kirin Co., Ltd.24 enrolled9 locationsNCT06525636
Recruiting

Effect of Hypophosphatemia on Neuro-excursion Efficiency During Mechanical Ventilator Weaning

HypophosphatemiaMechanical VentilationWeaning Failure
Peking Union Medical College70 enrolled1 locationNCT06754670
Recruiting
Phase 4

IV Iron-induced Hypophosphatemia After RYGB

Roux-en-Y gastric bypassHypophosphatemia
Lucie Favre94 enrolled1 locationNCT06350955